MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/25310429.2025.2460868

Медицинская библиотека · Pulmonology · 2025

German Asthma Net: Characterisation of responders to anti-IL-5 and anti-IL-5(R) therapy.

Bal Christina, Stoshikj Slagjana, Renner Andreas, Milger Katrin, Skowasch Dirk, Schulz Christian, Jandl Margret, Schmidt Olaf, Ehmann Rainer, Zehetmayer Sonja, Taube Christian, Hamelmann Eckard, Buhl Roland, Korn Stephanie, Idzko Marco

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Previous studies of anti-IL-5/IL-5(R) therapies in severe asthma found that response was mainly predicted by indicators of good baseline disease control. However, long-term response predictors remain unclear.

METHODS

Responders to anti-IL-5/IL-5(R) therapy in the well-characterised, real-life, international German Asthma Net (GAN) registry were analysed using regression analyses. Response was defined by ≥50% reduction in exacerbations or corticosteroid dose, super-response by a complete stop of both, and remission additionally by controlled asthma (ACT score≥20).

RESULTS

Seventy-seven percent of 347 patients (55% female, 56.6±12.3 years, follow-up 20.3±13 months) were responders and showed improved exacerbation rates, asthma control, and corticosteroid treatment reduction. Response was independently predicted by inhaled corticosteroid dose (odds ratio [OR] 1.5; p = 0.014), exacerbation rate (OR 1.2; p = 0.009), and treatment duration (OR 1.05, p = 0.023). Univariately, blood eosinophil counts notably predicted response (OR 12.4; p = 0.004). Super-response was inversely associated with corticosteroid dependence and depression. Remission was associated with the absence of systemic corticosteroids, better asthma control, and FEV1 in litre.

CONCLUSIONS

These results underscore that long-term anti-IL-5/IL-5(R) therapy reduces exacerbation and corticosteroid burden, especially in patients with severe disease and high type 2 inflammatory burden. Contrastingly, low baseline corticosteroid use and markers of good asthma control predicted remission and super-responder status.

Для цитирования: Bal Christina, Stoshikj Slagjana, Renner Andreas, Milger Katrin, Skowasch Dirk, Schulz Christian, Jandl Margret, Schmidt Olaf, Ehmann Rainer, Zehetmayer Sonja, Taube Christian, Hamelmann Eckard, Buhl Roland, Korn Stephanie, Idzko Marco. German Asthma Net: Characterisation of responders to anti-IL-5 and anti-IL-5(R) therapy.. Pulmonology. 2025. DOI: 10.1080/25310429.2025.2460868.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.